Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
Clinical trial NCT05263492 · TERMINATED
Trial details
- NCT number
- NCT05263492
- Sponsor
- Virginia Commonwealth University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2024-09-13
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.